Drug intelligence / Profile preview

Coronatix

Development stage
Unknown
Lead developer
Bharat Biotech
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Coronatix is a brand name for a COVID-19 vaccine, specifically associated with the inactivated virus vaccine technology. It is designed to stimulate an immune response against SARS-CoV-2 by introducing chemically inactivated virus particles into the body. These particles are unable to replicate but retain the structural proteins, such as the spike protein, necessary for the immune system to recognize the pathogen. Upon administration, antigen-presenting cells process the viral proteins and trigger the production of neutralizing antibodies and T-cell responses. This modality is a traditional vaccine approach used to provide broad protection against the virus and its variants by exposing the immune system to the entire virion rather than a single protein.

Brand names
Coronatix
02

Targets

SARS-CoV-2 spike

Beyond the preview

Go deeper on Coronatix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coronatix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call